Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
Clinical trial NCT06928818 · RECRUITING
Trial details
- NCT number
- NCT06928818
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-26
- Primary completion
- 2028-09-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.